Showing results (31-40 of 63) with videos related to
Sort By:
Pageof 7
Nanomedicine (London, England)|January 9, 2023
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapyRiham M Abdelgalil, Yomna M Elmorshedy, Kadria A Elkhodairy, et al.Acta Tropica|February 21, 2026
Early Diagnosis of Acute Experimental Toxoplasmosis via SAG1 Detection Using Nitrogen-Doped Carbon Dot-Based Sandwich ELISALobna A El-Zawawy, Mona M El Temsahy, Nehal Nassef Hezema, et al.Molecules (Basel, Switzerland)|November 21, 2014
TOMBU and COMBU as Novel Uronium-type peptide coupling reagents derived from Oxyma-BYahya E Jad, Sherine N Khattab, Beatriz G de la Torre, et al.Colloids and Surfaces. B, Biointerfaces|February 6, 2020
Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapyOmnia M Ali, Adnan A Bekhit, Sherine N Khattab, et al.Organic & Biomolecular Chemistry|September 20, 2014
Oxyma-B, an excellent racemization suppressor for peptide synthesisYahya E Jad, Sherine N Khattab, Beatriz G de la Torre, et al.Bioconjugate Chemistry|August 16, 2018
Lactobionic/Folate Dual-Targeted Amphiphilic Maltodextrin-Based Micelles for Targeted Codelivery of Sulfasalazine and Resveratrol to Hepatocellular CarcinomaDoaa M Anwar, Sherine N Khattab, Maged W Helmy, et al.Chemmedchem|September 21, 2021
Engineered s-Triazine-Based Dendrimer-Honokiol Conjugates as Targeted MMP-2/9 Inhibitors for Halting Hepatocellular CarcinomaHosam H Khalil, Heba A Osman, Mohamed Teleb, et al.Nanomedicine (London, England)|June 30, 2021
Recent advances in polymer shell oily-core nanocapsules for drug-delivery applicationsAhmed S AbdElhamid, Dina G Zayed, Lamia Heikal, et al.ACS Omega|February 23, 2023
Engineered Sericin-Tagged Layered Double Hydroxides for Combined Delivery of Pemetrexed and ZnO Quantum Dots as Biocompatible Cancer NanotheranosticsRiham M Abdelgalil, Sherine N Khattab, Shaker Ebrahim, et al.International Journal of Biological Macromolecules|February 24, 2025
Lipopolysaccharide nanomedicine-based reversion of chemotherapy-induced metastatic potential of breast cancer via hampering tumoral TLR4/SIRT2 axis and IL6 secretion from tumor-associated macrophagesYosra S Mahmoud, Islam A Hassanin, Sally A Sabra, et al.Pageof 7